Recently, in addition to FoxP3+ T cells, IL-10-producing CD4+ T (CD4+IL-10+ T) cells have also attracted considerable attention in GVHD cell therapy because of the exertion of their negative immunomodulatory effects. This evidence concerns the gene IL10 and graft versus host disease.